All News

2070 articles, sorted by publication time.

Biomedicine · global

Where Weight-Loss Drugs and Cancer Risk Intersect: GLP-1 Research Pushes Metabolic Treatment Into Oncology Questions

Multiple observational analyses at ASCO show lower-risk signals among GLP-1 receptor agonist users in breast cancer incidence, mortality, and metastatic progression in some cancers; this is not a definitive conclusion that they are anticancer therapies, but it makes the links among metabolism, obesity, and tumor biology harder to ignore.

biology · global

HPV-Positive Oropharyngeal Cancer Drug Pipeline Heats Up, but Clinical Evidence Remains Key Behind the Momentum

DelveInsight says at least five major pharmaceutical companies are investing in HPV-positive oropharyngeal cancer R&D, showing that this field, formed at the intersection of viruses, immunity, and head and neck cancer, is expanding; however, publicly available information remains limited, and a “robust” pipeline does not mean patients are already close to new therapies.